To study the effect of retained subretinal perfluorocarbon liquid (PFCL) on retinal function.
P erfluorocarbon liquid (PFCL) is commonly used in the surgical management of complicated retinal detachments and proliferative vitreoretinopathy. PFCL has a higher specific gravity than water and is optically clear. This makes it useful in displacing subretinal fluid, unfolding giant retinal tears, and providing stabilization of the retina during surgery for proliferative vitreoretinopathy. However, a potential complication of PFCL is that it can be retained within the eye, specifically in the subretinal space. This is most likely to occur in the presence of large peripheral retinotomies and in the absence of a saline rinse during fluid-air exchange done to remove the PFCL. 1 The rate of retained subretinal perfluoro-n-octane (PFO) (Perfluoron, Alcon Laboratories, Inc., Fort Worth, TX) and perfluoroperhydrophenanthrene (Vitreon) 6 months after surgery ranges from 1% to 11.1%. [1] [2] [3] Reports on the effect of prolonged retention of subretinal PFCL on retinal function have been variable. One report showed that functional changes from retained subfoveal perfluorodecalin may result in a permanent scotoma even after the perfluorodecalin bubble was removed, 4 but a recent case report showed visual acuity of 20/40 despite 10 years of retained subfoveal PFO. 5 In this study we describe possibly reversible changes in retinal sensitivity, as measured by scanning laser ophthalmoscope (SLO) microperim-etry (Rodenstock, Munich, Germany), associated with retained subretinal PFO.
We describe the following surgical cases in which PFCL was used.
Case Reports

Case 1
A 58-year-old woman was referred to our institution with a history of prior retinal detachment repair by scleral buckling and pars plana vitrectomy in the left eye. Fundus examination revealed a total retinal detachment with proliferative vitreoretinopathy. Subsequently, a pars plana vitrectomy and 360 degree peripheral retinectomy was performed and the retina was reattached using PFO. After fluid-air exchange and removal of the PFO, silicone oil was injected. Postoperatively, a droplet of PFO, approximately one disk area in size, was noted in the subretinal space approximately one disk diameter superotemporal to the optic nerve. Considering the location of the droplet outside the vascular arcade, surgical removal was not recommended. The subretinal PFCL droplet gradually moved inferiorly in the months after the surgery ( Figure 1A ). Silicone oil was removed 6 months after surgery. The droplet moved inferiorly 1,549 m in the first 40 months postoperatively. On clinical ophthalmoscopy, there was retinal pigment epithelium rarefaction at the original location of the droplet and along its path of migration ( Figure 1B ). SLO microperimetry was performed 41 months after surgery and an absolute scotoma to the highest stimulus intensity (72 cd/m 2 at 0 dB of attenuation) was found at the site of the subretinal PFO droplet. In the area vacated by the migrating subretinal PFO, the highest intensity stimulus could be detected; however, with 10 dB of attenuation, the target, although perceived in the surrounding retina, could not be perceived in the vacated area (a relative scotoma) ( Figure 1 , C and D).
Case 2
A 59-year-old woman presented with a rhegmatogenous retinal detachment and proliferative vitreoretinopathy in the right eye. The patient had undergone two prior retinal detachment surgeries. PFO was used as part of a vitrectomy procedure to achieve retinal reattachment. Postoperatively, the retina remained attached but there were three small droplets of PFCL in the subretinal space. At 12 months follow-up, the subretinal PFCL droplets had not moved and the surrounding retina appeared normal. At this time, SLO microperimetry was performed and revealed absolute scotomas at the areas where the three subretinal PFCL droplets were located.
Case 3
A 44-year-old woman presented with a rhegmatogenous retinal detachment of the right eye. She underwent a combined pars plana vitrectomy and scleral buckle to the right eye. She presented 1 month later with a recurrent retinal detachment in the right eye. Pars plana vitrectomy with intraoperative use of PFO was performed and silicone oil tamponade was used. Postoperatively, a small PFO bubble was noted beneath the nasal retina. It was observed for 12 months and no changes in the retina surrounding the droplet were observed. SLO microperimetry was performed and revealed an absolute scotoma at the droplet.
Case 4
A 50-year-old woman underwent combined pars plana vitrectomy and scleral buckle in the left eye for a retinal detachment associated with a giant retinal tear. PFO was used at the time of surgery to aid in the unfolding of the giant tear. Postoperatively, a subfoveal PFO droplet was identified (Figure 2A ). Visual acuity in the left eye was 20/200. The patient declined surgical intervention to remove the subretinal droplet. Five months later, the patient underwent cataract extraction with posterior chamber intraocular lens implantation in the left eye. SLO microperimetry was performed 4 months after cataract extraction and revealed an absolute central scotoma at the site of the retained subretinal PFCL ( Figure 2B ). Visual acuity remained 20/200 in this eye 1 year after initial presentation. 
Discussion
Studies of the long-term effects of intravitreal PFO and perfluorodecalin have shown various degrees of morphologic retinal damage. The effects have been located primarily in the inferior retina, suggesting mechanical rather than toxic damage. 6 -8 There is histopathologic evidence of an inflammatory response to retained intravitreal PFO. 9 Retained subretinal PFCL has been reported to cause underlying retinal pigment epithelium atrophy and poor central vision. 10, 11 Given that subretinal PFCL is in direct apposition with retinal pigment epithelium and photoreceptors, this may prevent functional communication between these structures. Additionally, animal studies have shown that injection of subretinal perfluorodecalin leads to loss of photoreceptor inner and outer segments and local retinal necrosis. 12 In this study, we present four cases in which retained subretinal PFCL was associated with changes in retinal sensitivity. In the first case, movement of the droplet during the postoperative period was associated with a relative scotoma in the area where the droplet was originally located and an absolute scotoma at the site of its new location. This may have resulted from a transient dysfunction of the overlying retina, suggesting that removal of the droplet could result in partial visual recovery. Visual acuity recovery has in fact been documented after removal of subretinal PFCL. 13 Cases 2 and 3 provide additional evidence for retinal dysfunction associated with subretinal PFCL. In Case 4, the subretinal PFCL was located at the fovea, resulting in a clinically significant central scotoma.
This case series suggests that subretinal PFCL can cause local changes in the sensitivity of the retina, as demonstrated by SLO microperimetry. Multifocal electroretinography would have been helpful in quantifying this more accurately but was not available when these patients were treated. The finding that movement of a droplet was associated with a relative scotoma suggests that partial recovery of function is possible if subretinal PFCL is removed. Just how long functional recovery might occur is not known. In Case 1, the droplet movement was calculated by measuring the distance from the uppermost pigment changes (previous PFCL bubble location) to the top of the migrated bubble. This inferior migration was measured to be 1549 m in the first 40 months after surgery, or 38.7 m per month. By taking the vertical diameter of the bubble, 1424 m, and dividing by the rate of migration, the bubble was calculated to be beneath a single point in the retina for as long as 36.8 months during the initial postoperative period. Although partial recovery of function occurred after this length of time, this cannot be used as a guideline for the timing of surgical intervention. At this time there was significant pigment epithelial atrophy throughout the area vacated by the migrating bubble and recovery was only partial as evidenced by the persistent relative scotoma. It is also possible that function may not recover at all in some eyes after this duration. Hence, subretinal PFCL beneath the fovea or at risk for migration beneath the fovea may be associated with a poor visual outcome and surgical removal of PFCL should be considered in these cases.
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